Animal Models of Primary Biliary Cirrhosis

Clinics in Liver Disease

Volumn 12, Issue 2, 2008, Pages 333-347

  Chuang, Ya Hui ^a   Ridgway, William M ^b   Ueno, Yoshiyuki ^c   Gershwin, M Eric ^d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 2 RECEPTOR ALPHA;

CLINICAL FEATURE; DISEASE COURSE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; REVIEW; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED NOD; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 43049121706     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2008.02.011     Document Type: Review

References (71)

1. Allina J., Hu B., Sullivan D.M., et al. T cell targeting and phagocytosis of apoptotic biliary epithelial cells in primary biliary cirrhosis. J Autoimmun 27 (2006) 232-241
2. He X.S., Ansari A.A., Ridgway W.M., et al. New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell Immunol 239 (2006) 1-13
3. Gershwin M.E., Ansari A.A., Mackay I.R., et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev 174 (2000) 210-225
4. Oertelt S., Rieger R., Selmi C., et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45 (2007) 659-665
5. Gershwin M.E., Mackay I.R., Sturgess A., et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138 (1987) 3525-3531
6. Van de Water J., Gershwin M.E., Leung P., et al. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 167 (1988) 1791-1799
7. Shimoda S., Van de Water J., Ansari A., et al. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. J Clin Invest 102 (1998) 1831-1840
8. Kita H., Ansari A.A., He X.S., et al. Proteasome is required for class I-restricted presentation by Fcgamma receptor-mediated endocytosis in primary biliary cirrhosis. J Autoimmun 21 (2003) 175-182
9. Kita H., Matsumura S., He X.S., et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest 109 (2002) 1231-1240
10. Tanimoto H., Shimoda S., Nakamura M., et al. Promiscuous T cells selected by Escherichia coli: OGDC-E2 in primary biliary cirrhosis. J Autoimmun 20 (2003) 255-263
11. Leon M.P., Bassendine M.F., and Wilson J.L. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology 24 (1996) 561-567
12. Hashimoto E., Lindor K.D., Homburger H.A., et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 68 (1993) 1049-1055
13. Harada K., Van de Water J., Leung P.S., et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset. Hepatology 25 (1997) 791-796
14. Lan R.Y., Cheng C., Lian Z.X., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
15. Aoki C.A., Roifman C.M., Lian Z.X., et al. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J Autoimmun 27 (2006) 50-53
16. Nakamura M., Takii Y., Ito M., et al. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis. J Autoimmun 26 (2006) 138-145
17. Kikuchi K., Lian Z.X., Yang G.X., et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 128 (2005) 304-312
18. Moritoki Y., Lian Z.X., Wulff H., et al. AMA production in primary biliary cirrhosis is promoted by the TLR9 ligand CpG and suppressed by potassium channel blockers. Hepatology 45 (2007) 314-322
19. Selmi C., Invernizzi P., Keeffe E.B., et al. Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol 38 (2004) 264-271
20. Invernizzi P., Miozzo M., Battezzati P.M., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363 (2004) 533-535
21. Selmi C., Mayo M.J., Bach N., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127 (2004) 485-492
22. Chuang Y.H., Lian Z.X., Cheng C.M., et al. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun 25 (2005) 126-132
23. Salunga T.L., Cui Z.G., Shimoda S., et al. Oxidative stress-induced apoptosis of bile duct cells in primary biliary cirrhosis. J Autoimmun 29 (2007) 78-86
24. Koizumi H., Matsumura T., Kumakiri M., et al. Generalized granuloma annulare with primary biliary cirrhosis. Nippon Hifuka Gakkai Zasshi 100 (1990) 871-878 [in Japanese]
25. Van de Water J., Ansari A., Prindiville T., et al. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181 (1995) 723-733
26. Scheuer P.J. Ludwig symposium on biliary disorders-part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis. Mayo Clin Proc 73 (1998) 179-183
27. Nakanuma Y., Saito K., and Unoura M. Semiquantitative assessment of cholestasis and lymphocytic piecemeal necrosis in primary biliary cirrhosis: a histologic and immunohistochemical study. J Clin Gastroenterol 12 (1990) 357-362
28. Ludwig J. New concepts in biliary cirrhosis. Semin Liver Dis 7 (1987) 293-301
29. Anderson M.S., and Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23 (2005) 447-485
30. Aoki C.A., Borchers A.T., Ridgway W.M., et al. NOD mice and autoimmunity. Autoimmun Rev 4 (2005) 373-379
31. Ogawa N., Minamimura K., Kodaka T., et al. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. J Autoimmun 26 (2006) 225-231
32. Hu Y., Nakagawa Y., Purushotham K.R., et al. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am J Physiol 263 (1992) E607-E614
33. Yu S., Sharp G.C., and Braley-Mullen H. Dual roles for IFN-gamma, but not for IL-4, in spontaneous autoimmune thyroiditis in NOD.H-2h4 mice. J Immunol 169 (2002) 3999-4007
34. Salomon B., Rhee L., Bour-Jordan H., et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194 (2001) 677-684
35. Gao J., Killedar S., Cornelius J.G., et al. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J Autoimmun 26 (2006) 90-103
36. Lyons P.A., Hancock W.W., Denny P., et al. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 13 (2000) 107-115
37. Koarada S., Wu Y., Fertig N., et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 173 (2004) 2315-2323
38. Irie J., Wu Y., Wicker L.S., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 203 (2006) 1209-1219
39. Nakagome Y., Ueno Y., Kogure T., et al. Autoimmune cholangitis in NOD.c3c4 mice is associated with cholangiocyte-specific Fas antigen deficiency. J Autoimmun 29 (2007) 20-29
40. Todd J.A., and Wicker L.S. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 15 (2001) 387-395
41. Holzer U., Rieck M., and Buckner J.H. Lineage and signal strength determine the inhibitory effect of transforming growth factor beta1 (TGF-beta1) on human antigen-specific Th1 and Th2 memory cells. J Autoimmun 26 (2006) 241-251
42. Li M.O., Wan Y.Y., Sanjabi S., et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24 (2006) 99-146
43. Kulkarni A.B., Huh C.G., Becker D., et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 90 (1993) 770-774
44. Weiner H.L. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 3 (2001) 947-954
45. Chen W., Jin W., Hardegen N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
46. Peng J., Dicker B., Du W., et al. Converting antigen-specific diabetogenic CD4 and CD8 T cells to TGF-beta producing non-pathogenic regulatory cells following FoxP3 transduction. J Autoimmun 28 (2007) 188-200
47. Tanaka A., Nalbandian G., Leung P.S., et al. Mucosal immunity and primary biliary cirrhosis: presence of antimitochondrial antibodies in urine. Hepatology 32 (2000) 910-915
48. Oertelt S., Lian Z.X., Cheng C.M., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 177 (2006) 1655-1660
49. Kita H., Naidenko O.V., Kronenberg M., et al. Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123 (2002) 1031-1043
50. Tsuneyama K., Yasoshima M., Harada K., et al. Increased CD1d expression on small bile duct epithelium and epithelioid granuloma in livers in primary biliary cirrhosis. Hepatology 28 (1998) 620-623
51. Chuang Y.H., Lian Z.X., Yang G.X., et al. Natural killer T cells exacerbate liver injury in a transforming growth factor β receptor II dominant-negative mouse model of primary biliary cirrhosis. Hepatology 47 (2008) 571-580
52. Fontenot J.D., Rasmussen J.P., Gavin M.A., et al. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
53. Willerford D.M., Chen J., Ferry J.A., et al. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3 (1995) 521-530
54. Wakabayashi K., Lian Z.X., Moritoki Y., et al. IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis. Hepatology 44 (2006) 1240-1249
55. Jones D.E., Palmer J.M., Yeaman S.J., et al. Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis. Hepatology 30 (1999) 65-70
56. Palmer J.M., Robe A.J., Burt A.D., et al. Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse. Hepatology 39 (2004) 1583-1592
57. Leung P.S., Quan C., Park O., et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 170 (2003) 5326-5332
58. Rieger R., and Gershwin M.E. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 28 (2007) 76-84
59. Avrameas S., Ternynck T., and Tsonis I.A. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29 (2007) 213-218
60. Cohen I.R. Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29 (2007) 246-249
61. Lan R.Y., Mackay I.R., and Eric Gershwin M. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29 (2007) 272-280
62. Lang K.S., Burow A., Kurrer M., et al. The role of the innate immune response in autoimmune disease. J Autoimmun 29 (2007) 206-212
63. Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29 (2007) 287-294
64. Milner J., Ward J., Keane-Myers A., et al. Repertoire-dependent immunopathology. J Autoimmun 29 (2007) 257-261
65. Papadimitraki E.D., Bertsias G.K., and Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29 (2007) 310-318
66. Pasquali J.L., Soulas-Sprauel P., Korganow A.S., et al. Auto-reactive B cells in transgenic mice. J Autoimmun 29 (2007) 250-256
67. Peng Y., Martin D.A., Kenkel J., et al. Innate and adaptive immune response to apoptotic cells. J Autoimmun 29 (2007) 303-309
68. Rowley B., Tang L., Shinton S., et al. Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29 (2007) 236-245
69. Tsonis I.A., Avrameas S., and Moutsopoulos H.M. Autoimmunity and pathophysiology. J Autoimmun 29 (2007) 203-205
70. Zhou Z.H., Tzioufas A.G., and Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29 (2007) 219-228
71. Gorelik L., and Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12 (2000) 171-181